These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Mar 26, 2009
Warrington, PA — March 26, 2009 — Discovery Laboratories, Inc. (Nasdaq: DSCO) today announces that it has created a lyophilized formulation of its synthetic, peptide-containing KL4...
Mar 13, 2009
Warrington, PA — March 13, 2009 — Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced financial results for the fourth quarter ended December 31, 2008. For the quarter ended...
Jan 5, 2009
Warrington, PA – January 5, 2009, -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announces the publication of results from its Phase 2 clinical trial of Surfaxin® for the prevention and...
Apr 27, 2002Discovery Labs Presents Pharmacoeconomic Data Linking Decreased Hospital Costs to Reduction in Reintubation Following Surfaxin Use
Warrington, PA — April 27, 2009 — Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it presented a pharmacoeconomic analysis of data from its SELECT and STAR Phase 3...